A Study of KITE-363 in Participants With Refractory Autoimmune Diseases

Clinical trial NCT07038447 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07038447
Sponsor: Kite, A Gilead Company
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Lupus Nephritis Systemic Sclerosis Idiopathic Inflammatory Myopathy

Start date: 2025-07-02
Primary completion: 2029-07-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.